サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1716056

AI病理診断プラットフォームの世界市場に関する洞察、2031年までの予測

Global AI Pathological Diagnosis Platform Market Insights, Forecast to 2031

出版日
発行
QYResearch
ページ情報
英文 139 Pages
納期
2～3営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
AI病理診断プラットフォームの世界市場に関する洞察、2031年までの予測
出版日: 2025年05月01日
発行: QYResearch
ページ情報: 英文 139 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、AI病理診断プラットフォーム (AI Pathological Diagnosis Platform) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 調査範囲
  • 市場分析：タイプ別
    • 世界のAI病理診断プラットフォームの市場規模成長率：タイプ別: 2020 VS 2024 VS 2031
    • Image Recognition-Based AI Pathological Platforms
    • Deep Learning-Based AI Pathological Platforms
    • Integrated Workflow Pathology Platforms
    • Multimodal Diagnostic Platforms
    • Others
  • 市場：用途別
    • 世界のAI病理診断プラットフォームの市場シェア：用途別: 2020 VS 2024 VS 2031
    • Cancer Screening and Diagnosis
    • Tissue and Cellular Pathology Analysis
    • Surgical Margin Assessment
    • Digital Pathology Data Management
    • Others
  • 前提条件と制限
  • 調査目的
  • 対象期間

第2章 世界の市場成長トレンド

  • 世界のAI病理診断プラットフォームの市場展望 (2020-2031)
  • 世界のAI病理診断プラットフォームの市場成長トレンド：地域別
    • 世界のAI病理診断プラットフォーム 市場規模：地域別: 2020 VS 2024 VS 2031
    • AI病理診断プラットフォーム 市場規模：地域別 (2020-2031)
  • AI病理診断プラットフォーム 市場動向
    • AI病理診断プラットフォーム 業界動向
    • AI病理診断プラットフォーム 市場の促進要因
    • AI病理診断プラットフォーム 市場の課題
    • AI病理診断プラットフォーム 市場の抑制要因

第3章 競合情勢：主要企業別

  • 世界の収益 AI病理診断プラットフォーム ：競合別
    • 世界のAI病理診断プラットフォームの収益：企業別 (2020-2025)
    • 世界のAI病理診断プラットフォームの収益シェア：企業別 (2020-2025)
  • 世界のAI病理診断プラットフォームの市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 世界の主要企業 AI病理診断プラットフォーム, 売上高ランキング, 2023 VS 2024 VS 2025
  • 世界の市場集中度
    • 世界のAI病理診断プラットフォーム 市場集中度 (CR5 and HHI)
    • 世界の上位10・上位5企業： AI病理診断プラットフォーム 収益 2024年
  • 世界の主要企業 AI病理診断プラットフォーム 本社 および提供地域
  • 世界の主要企業 AI病理診断プラットフォーム, 製品およびアプリケーション
  • 世界の主要企業 AI病理診断プラットフォーム, 業界参入時期
  • M&A, 拡張計画

第4章 内訳データ：タイプ別

  • 世界のAI病理診断プラットフォームの市場規模実績：タイプ別 (2020-2025)
  • 世界のAI病理診断プラットフォームの市場規模予測：タイプ別 (2026-2031)

第5章 内訳データ：用途別

  • 世界のAI病理診断プラットフォームの市場規模実績：用途別 (2020-2025)
  • 世界のAI病理診断プラットフォームの市場規模予測：用途別 (2026-2031)

第6章 北米

  • 北米のAI病理診断プラットフォーム 市場規模 (2020-2031)
  • 北米の市場規模：タイプ別
    • 北米のAI病理診断プラットフォーム 市場規模：タイプ別 (2020-2031)
    • 北米のAI病理診断プラットフォームの市場シェア：タイプ別 (2020-2031)
  • 北米の市場規模：用途別
    • 北米のAI病理診断プラットフォーム 市場規模：用途別 (2020-2031)
    • 北米のAI病理診断プラットフォームの市場シェア：用途別 (2020-2031)
  • 北米の市場規模：国別
    • 北米のAI病理診断プラットフォーム 市場規模：国別: 2020 VS 2024 VS 2031
    • 北米のAI病理診断プラットフォーム 市場規模：国別 (2020-2031)
    • 米国
    • カナダ

第7章 欧州

  • 欧州のAI病理診断プラットフォーム 市場規模 (2020-2031)
  • 欧州の市場規模：タイプ別
    • 欧州のAI病理診断プラットフォーム 市場規模：タイプ別 (2020-2031)
    • 欧州のAI病理診断プラットフォームの市場シェア：タイプ別 (2020-2031)
  • 欧州の市場規模：用途別
    • 欧州のAI病理診断プラットフォーム 市場規模：用途別 (2020-2031)
    • 欧州のAI病理診断プラットフォームの市場シェア：用途別 (2020-2031)
  • 欧州の市場規模：国別
    • 欧州のAI病理診断プラットフォーム 市場規模：国別: 2020 VS 2024 VS 2031
    • 欧州のAI病理診断プラットフォーム 市場規模：国別 (2020-2025)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
    • 北欧

第8章 中国

  • 中国のAI病理診断プラットフォーム 市場規模 (2020-2031)
  • 中国の市場規模：タイプ別
    • 中国のAI病理診断プラットフォーム 市場規模：タイプ別 (2020-2031)
    • 中国のAI病理診断プラットフォームの市場シェア：タイプ別 (2020-2031)
  • 中国の市場規模：用途別
    • 中国のAI病理診断プラットフォーム 市場規模：用途別 (2020-2031)
    • 中国のAI病理診断プラットフォームの市場シェア：用途別 (2020-2031)

第9章 アジア（中国を除く）

  • アジア地域 AI病理診断プラットフォーム 市場規模 (2020-2031)
  • アジア地域 市場規模：タイプ別
    • アジア地域 AI病理診断プラットフォーム 市場規模：タイプ別 (2020-2031)
    • アジア地域 AI病理診断プラットフォームの市場シェア：タイプ別 (2020-2031)
  • アジア地域 市場規模：用途別
    • アジア地域 AI病理診断プラットフォーム 市場規模：用途別 (2020-2031)
    • アジア地域 AI病理診断プラットフォームの市場シェア：用途別 (2020-2031)
  • アジア地域 市場規模：地域別
    • アジア地域 AI病理診断プラットフォーム 市場規模：地域別: 2020 VS 2024 VS 2031
    • アジア地域 AI病理診断プラットフォーム 市場規模：地域別 (2020-2031)
    • 日本
    • 韓国
    • 台湾
    • 東南アジア
    • インド
    • オーストラリア

第10章 中近東・アフリカ・中南米

  • 中近東・アフリカ・中南米 AI病理診断プラットフォーム 市場規模 (2020-2031)
  • 中近東・アフリカ・中南米 市場規模：タイプ別
    • 中近東・アフリカ・中南米 AI病理診断プラットフォーム 市場規模：タイプ別 (2020-2031)
    • 中近東・アフリカ・中南米 AI病理診断プラットフォームの市場シェア：タイプ別 (2020-2031)
  • 中近東・アフリカ・中南米 市場規模：用途別
    • 中近東・アフリカ・中南米 AI病理診断プラットフォーム 市場規模：用途別 (2020-2031)
    • 中近東・アフリカ・中南米の市場シェア：用途別 (2020-2031)
  • 中近東・アフリカ・中南米 市場規模：国別
    • 中近東・アフリカ・中南米 AI病理診断プラットフォーム 市場規模：国別: 2020 VS 2024 VS 2031
    • 中近東・アフリカ・中南米 AI病理診断プラットフォーム 市場規模：国別 (2020-2031)
    • ブラジル
    • メキシコ
    • トルコ
    • サウジアラビア
    • イスラエル
    • 湾岸協力理事会諸国

第11章 主要企業のプロファイル

  • Philips Healthcare
  • Roche Diagnostics
  • Siemens Healthineers
  • GE HealthCare
  • Paige AI
  • PathAI
  • Proscia
  • Aiforia Technologies
  • Ibex Medical Analytics
  • Agfa-Gevaert Group
  • Indica Labs
  • Deep Bio Inc.
  • Visiopharm
  • Techcyte
  • Hologic Inc.

第12章 アナリストによる分析/結論

第13章 付録

図表

List of Tables

Table 1. Global AI Pathological Diagnosis Platform Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Image Recognition-Based AI Pathological Platforms

Table 3. Key Players of Deep Learning-Based AI Pathological Platforms

Table 4. Key Players of Integrated Workflow Pathology Platforms

Table 5. Key Players of Multimodal Diagnostic Platforms

Table 6. Key Players of Others

Table 7. Global AI Pathological Diagnosis Platform Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global AI Pathological Diagnosis Platform Market Size Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Market Size by Region (2020-2031) & (US$ Million)

Table 10. Global AI Pathological Diagnosis Platform Market Share by Region (2020-2031)

Table 11. Market Trends

Table 12. Market Drivers

Table 13. Market Challenges

Table 14. Market Restraints

Table 15. Global AI Pathological Diagnosis Platform Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global AI Pathological Diagnosis Platform Market Share by Players (2020-2025)

Table 17. Global Top AI Pathological Diagnosis Platform Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI Pathological Diagnosis Platform as of 2024)

Table 18. Global AI Pathological Diagnosis Platform Industry Ranking 2023 VS 2024

Table 19. Global 5 Largest Players Market Share by AI Pathological Diagnosis Platform Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of AI Pathological Diagnosis Platform, Headquarters and Area Served

Table 21. Global Key Players of AI Pathological Diagnosis Platform, Product and Application

Table 22. Global Key Players of AI Pathological Diagnosis Platform, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global AI Pathological Diagnosis Platform Revenue Market Share by Type (2020-2025)

Table 26. Global Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global AI Pathological Diagnosis Platform Revenue Market Share by Type (2026-2031)

Table 28. Global Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global AI Pathological Diagnosis Platform Revenue Market Share by Application (2020-2025)

Table 30. Global Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global AI Pathological Diagnosis Platform Revenue Market Share by Application (2026-2031)

Table 32. North America Market Size by Type (2020-2031) & (US$ Million)

Table 33. North America Market Size by Application (2020-2031) & (US$ Million)

Table 34. North America AI Pathological Diagnosis Platform Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Market Size by Country (2020-2031) & (US$ Million)

Table 36. Europe Market Size by Type (2020-2031) & (US$ Million)

Table 37. Europe Market Size by Application (2020-2031) & (US$ Million)

Table 38. Europe AI Pathological Diagnosis Platform Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031

Table 39. Europe Market Size by Country (2020-2025) & (US$ Million)

Table 40. China Market Size by Type (2020-2031) & (US$ Million)

Table 41. China Market Size by Application (2020-2031) & (US$ Million)

Table 42. Asia Market Size by Type (2020-2031) & (US$ Million)

Table 43. Asia Market Size by Application (2020-2025) & (US$ Million)

Table 44. Asia AI Pathological Diagnosis Platform Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031

Table 45. Asia Market Size by Region (2020-2031) & (US$ Million)

Table 46. Middle East, Africa, and Latin America Market Size by Type (2020-2031) & (US$ Million)

Table 47. Middle East, Africa, and Latin America Market Size by Application (2020-2031) & (US$ Million)

Table 48. Middle East, Africa, and Latin America AI Pathological Diagnosis Platform Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031

Table 49. Middle East, Africa, and Latin America Market Size by Country (2020-2031) & (US$ Million)

Table 50. Philips Healthcare Company Details

Table 51. Philips Healthcare Business Overview

Table 52. Philips Healthcare AI Pathological Diagnosis Platform Product

Table 53. Philips Healthcare Revenue (2020-2025) & (US$ Million)

Table 54. Philips Healthcare Recent Development

Table 55. Roche Diagnostics Company Details

Table 56. Roche Diagnostics Business Overview

Table 57. Roche Diagnostics AI Pathological Diagnosis Platform Product

Table 58. Roche Diagnostics Revenue (2020-2025) & (US$ Million)

Table 59. Roche Diagnostics Recent Development

Table 60. Siemens Healthineers Company Details

Table 61. Siemens Healthineers Business Overview

Table 62. Siemens Healthineers AI Pathological Diagnosis Platform Product

Table 63. Siemens Healthineers Revenue (2020-2025) & (US$ Million)

Table 64. Siemens Healthineers Recent Development

Table 65. GE HealthCare Company Details

Table 66. GE HealthCare Business Overview

Table 67. GE HealthCare AI Pathological Diagnosis Platform Product

Table 68. GE HealthCare Revenue (2020-2025) & (US$ Million)

Table 69. GE HealthCare Recent Development

Table 70. Paige AI Company Details

Table 71. Paige AI Business Overview

Table 72. Paige AI AI Pathological Diagnosis Platform Product

Table 73. Paige AI Revenue (2020-2025) & (US$ Million)

Table 74. Paige AI Recent Development

Table 75. PathAI Company Details

Table 76. PathAI Business Overview

Table 77. PathAI AI Pathological Diagnosis Platform Product

Table 78. PathAI Revenue (2020-2025) & (US$ Million)

Table 79. PathAI Recent Development

Table 80. Proscia Company Details

Table 81. Proscia Business Overview

Table 82. Proscia AI Pathological Diagnosis Platform Product

Table 83. Proscia Revenue (2020-2025) & (US$ Million)

Table 84. Proscia Recent Development

Table 85. Aiforia Technologies Company Details

Table 86. Aiforia Technologies Business Overview

Table 87. Aiforia Technologies AI Pathological Diagnosis Platform Product

Table 88. Aiforia Technologies Revenue (2020-2025) & (US$ Million)

Table 89. Aiforia Technologies Recent Development

Table 90. Ibex Medical Analytics Company Details

Table 91. Ibex Medical Analytics Business Overview

Table 92. Ibex Medical Analytics AI Pathological Diagnosis Platform Product

Table 93. Ibex Medical Analytics Revenue (2020-2025) & (US$ Million)

Table 94. Ibex Medical Analytics Recent Development

Table 95. Agfa-Gevaert Group Company Details

Table 96. Agfa-Gevaert Group Business Overview

Table 97. Agfa-Gevaert Group AI Pathological Diagnosis Platform Product

Table 98. Agfa-Gevaert Group Revenue (2020-2025) & (US$ Million)

Table 99. Agfa-Gevaert Group Recent Development

Table 100. Indica Labs Company Details

Table 101. Indica Labs Business Overview

Table 102. Indica Labs AI Pathological Diagnosis Platform Product

Table 103. Indica Labs Revenue (2020-2025) & (US$ Million)

Table 104. Indica Labs Recent Development

Table 105. Deep Bio Inc. Company Details

Table 106. Deep Bio Inc. Business Overview

Table 107. Deep Bio Inc. AI Pathological Diagnosis Platform Product

Table 108. Deep Bio Inc. Revenue (2020-2025) & (US$ Million)

Table 109. Deep Bio Inc. Recent Development

Table 110. Visiopharm Company Details

Table 111. Visiopharm Business Overview

Table 112. Visiopharm AI Pathological Diagnosis Platform Product

Table 113. Visiopharm Revenue (2020-2025) & (US$ Million)

Table 114. Visiopharm Recent Development

Table 115. Techcyte Company Details

Table 116. Techcyte Business Overview

Table 117. Techcyte AI Pathological Diagnosis Platform Product

Table 118. Techcyte Revenue (2020-2025) & (US$ Million)

Table 119. Techcyte Recent Development

Table 120. Hologic Inc. Company Details

Table 121. Hologic Inc. Business Overview

Table 122. Hologic Inc. AI Pathological Diagnosis Platform Product

Table 123. Hologic Inc. Revenue (2020-2025) & (US$ Million)

Table 124. Hologic Inc. Recent Development

Table 125. Research Programs/Design for This Report

Table 126. Key Data Information from Secondary Sources

Table 127. Key Data Information from Primary Sources

List of Figures

Figure 1. Global AI Pathological Diagnosis Platform Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 2. Global AI Pathological Diagnosis Platform Market Share by Type: 2024 VS 2031

Figure 3. Image Recognition-Based AI Pathological Platforms Features

Figure 4. Deep Learning-Based AI Pathological Platforms Features

Figure 5. Integrated Workflow Pathology Platforms Features

Figure 6. Multimodal Diagnostic Platforms Features

Figure 7. Others Features

Figure 8. Global AI Pathological Diagnosis Platform Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 9. Global AI Pathological Diagnosis Platform Market Share by Application: 2024 VS 2031

Figure 10. Cancer Screening and Diagnosis Case Studies

Figure 11. Tissue and Cellular Pathology Analysis Case Studies

Figure 12. Surgical Margin Assessment Case Studies

Figure 13. Digital Pathology Data Management Case Studies

Figure 14. Others Case Studies

Figure 15. AI Pathological Diagnosis Platform Report Years Considered

Figure 16. Global AI Pathological Diagnosis Platform Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 17. Global AI Pathological Diagnosis Platform Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 18. Global AI Pathological Diagnosis Platform Market Share by Region: 2024 VS 2031

Figure 19. Global AI Pathological Diagnosis Platform Market Share by Players in 2024

Figure 20. Global Top AI Pathological Diagnosis Platform Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI Pathological Diagnosis Platform as of 2024)

Figure 21. The Top 10 and 5 Players Market Share by AI Pathological Diagnosis Platform Revenue in 2024

Figure 22. North America AI Pathological Diagnosis Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. North America AI Pathological Diagnosis Platform Market Share by Type (2020-2031)

Figure 24. North America AI Pathological Diagnosis Platform Market Share by Application (2020-2031)

Figure 25. North America AI Pathological Diagnosis Platform Market Share by Country (2020-2031)

Figure 26. United States AI Pathological Diagnosis Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Canada AI Pathological Diagnosis Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe AI Pathological Diagnosis Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Europe AI Pathological Diagnosis Platform Market Share by Type (2020-2031)

Figure 30. Europe AI Pathological Diagnosis Platform Market Share by Application (2020-2031)

Figure 31. Europe AI Pathological Diagnosis Platform Market Share by Country (2020-2031)

Figure 32. Germany AI Pathological Diagnosis Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. France AI Pathological Diagnosis Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. U.K. AI Pathological Diagnosis Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Italy AI Pathological Diagnosis Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Russia AI Pathological Diagnosis Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Nordic Countries AI Pathological Diagnosis Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. China AI Pathological Diagnosis Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. China AI Pathological Diagnosis Platform Market Share by Type (2020-2031)

Figure 40. China AI Pathological Diagnosis Platform Market Share by Application (2020-2031)

Figure 41. Asia AI Pathological Diagnosis Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Asia AI Pathological Diagnosis Platform Market Share by Type (2020-2031)

Figure 43. Asia AI Pathological Diagnosis Platform Market Share by Application (2020-2031)

Figure 44. Asia AI Pathological Diagnosis Platform Market Share by Region (2020-2031)

Figure 45. Japan AI Pathological Diagnosis Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. South Korea AI Pathological Diagnosis Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. China Taiwan AI Pathological Diagnosis Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Southeast Asia AI Pathological Diagnosis Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. India AI Pathological Diagnosis Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Australia AI Pathological Diagnosis Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Middle East, Africa, and Latin America AI Pathological Diagnosis Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Middle East, Africa, and Latin America AI Pathological Diagnosis Platform Market Share by Type (2020-2031)

Figure 53. Middle East, Africa, and Latin America AI Pathological Diagnosis Platform Market Share by Application (2020-2031)

Figure 54. Middle East, Africa, and Latin America AI Pathological Diagnosis Platform Market Share by Country (2020-2031)

Figure 55. Brazil AI Pathological Diagnosis Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 56. Mexico AI Pathological Diagnosis Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 57. Turkey AI Pathological Diagnosis Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 58. Saudi Arabia AI Pathological Diagnosis Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 59. Israel AI Pathological Diagnosis Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 60. GCC Countries AI Pathological Diagnosis Platform Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 61. Philips Healthcare Revenue Growth Rate in AI Pathological Diagnosis Platform Business (2020-2025)

Figure 62. Roche Diagnostics Revenue Growth Rate in AI Pathological Diagnosis Platform Business (2020-2025)

Figure 63. Siemens Healthineers Revenue Growth Rate in AI Pathological Diagnosis Platform Business (2020-2025)

Figure 64. GE HealthCare Revenue Growth Rate in AI Pathological Diagnosis Platform Business (2020-2025)

Figure 65. Paige AI Revenue Growth Rate in AI Pathological Diagnosis Platform Business (2020-2025)

Figure 66. PathAI Revenue Growth Rate in AI Pathological Diagnosis Platform Business (2020-2025)

Figure 67. Proscia Revenue Growth Rate in AI Pathological Diagnosis Platform Business (2020-2025)

Figure 68. Aiforia Technologies Revenue Growth Rate in AI Pathological Diagnosis Platform Business (2020-2025)

Figure 69. Ibex Medical Analytics Revenue Growth Rate in AI Pathological Diagnosis Platform Business (2020-2025)

Figure 70. Agfa-Gevaert Group Revenue Growth Rate in AI Pathological Diagnosis Platform Business (2020-2025)

Figure 71. Indica Labs Revenue Growth Rate in AI Pathological Diagnosis Platform Business (2020-2025)

Figure 72. Deep Bio Inc. Revenue Growth Rate in AI Pathological Diagnosis Platform Business (2020-2025)

Figure 73. Visiopharm Revenue Growth Rate in AI Pathological Diagnosis Platform Business (2020-2025)

Figure 74. Techcyte Revenue Growth Rate in AI Pathological Diagnosis Platform Business (2020-2025)

Figure 75. Hologic Inc. Revenue Growth Rate in AI Pathological Diagnosis Platform Business (2020-2025)

Figure 76. Bottom-up and Top-down Approaches for This Report

Figure 77. Data Triangulation

Figure 78. Key Executives Interviewed

目次

This research report focuses on the AI Pathological Diagnosis Platform Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global AI Pathological Diagnosis Platform Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
    • 1.2.2 Image Recognition-Based AI Pathological Platforms
    • 1.2.3 Deep Learning-Based AI Pathological Platforms
    • 1.2.4 Integrated Workflow Pathology Platforms
    • 1.2.5 Multimodal Diagnostic Platforms
    • 1.2.6 Others
  • 1.3 Market by Application
    • 1.3.1 Global AI Pathological Diagnosis Platform Market Share by Application: 2020 VS 2024 VS 2031
    • 1.3.2 Cancer Screening and Diagnosis
    • 1.3.3 Tissue and Cellular Pathology Analysis
    • 1.3.4 Surgical Margin Assessment
    • 1.3.5 Digital Pathology Data Management
    • 1.3.6 Others
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global AI Pathological Diagnosis Platform Market Perspective (2020-2031)
  • 2.2 Global AI Pathological Diagnosis Platform Growth Trends by Region
    • 2.2.1 Global AI Pathological Diagnosis Platform Market Size by Region: 2020 VS 2024 VS 2031
    • 2.2.2 AI Pathological Diagnosis Platform Market Size by Region (2020-2031)
  • 2.3 AI Pathological Diagnosis Platform Market Dynamics
    • 2.3.1 AI Pathological Diagnosis Platform Industry Trends
    • 2.3.2 AI Pathological Diagnosis Platform Market Drivers
    • 2.3.3 AI Pathological Diagnosis Platform Market Challenges
    • 2.3.4 AI Pathological Diagnosis Platform Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Revenue AI Pathological Diagnosis Platform by Players
    • 3.1.1 Global AI Pathological Diagnosis Platform Revenue by Players (2020-2025)
    • 3.1.2 Global AI Pathological Diagnosis Platform Revenue Market Share by Players (2020-2025)
  • 3.2 Global AI Pathological Diagnosis Platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Global Key Players of AI Pathological Diagnosis Platform, Ranking by Revenue, 2023 VS 2024 VS 2025
  • 3.4 Global Market Concentration Ratio
    • 3.4.1 Global AI Pathological Diagnosis Platform Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by AI Pathological Diagnosis Platform Revenue in 2024
  • 3.5 Global Key Players of AI Pathological Diagnosis Platform Head office and Area Served
  • 3.6 Global Key Players of AI Pathological Diagnosis Platform, Product and Application
  • 3.7 Global Key Players of AI Pathological Diagnosis Platform, Date of Enter into This Industry
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type

  • 4.1 Global AI Pathological Diagnosis Platform Historic Market Size by Type (2020-2025)
  • 4.2 Global AI Pathological Diagnosis Platform Forecasted Market Size by Type (2026-2031)

5 Breakdown Data by Application

  • 5.1 Global AI Pathological Diagnosis Platform Historic Market Size by Application (2020-2025)
  • 5.2 Global AI Pathological Diagnosis Platform Forecasted Market Size by Application (2026-2031)

6 North America

  • 6.1 North America AI Pathological Diagnosis Platform Market Size (2020-2031)
  • 6.2 North America Market Size by Type
    • 6.2.1 North America AI Pathological Diagnosis Platform Market Size by Type (2020-2031)
    • 6.2.2 North America AI Pathological Diagnosis Platform Market Share by Type (2020-2031)
  • 6.3 North America Market Size by Application
    • 6.3.1 North America AI Pathological Diagnosis Platform Market Size by Application (2020-2031)
    • 6.3.2 North America AI Pathological Diagnosis Platform Market Share by Application (2020-2031)
  • 6.4 North America Market Size by Country
    • 6.4.1 North America AI Pathological Diagnosis Platform Market Size by Country: 2020 VS 2024 VS 2031
    • 6.4.2 North America AI Pathological Diagnosis Platform Market Size by Country (2020-2031)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe AI Pathological Diagnosis Platform Market Size (2020-2031)
  • 7.2 Europe Market Size by Type
    • 7.2.1 Europe AI Pathological Diagnosis Platform Market Size by Type (2020-2031)
    • 7.2.2 Europe AI Pathological Diagnosis Platform Market Share by Type (2020-2031)
  • 7.3 Europe Market Size by Application
    • 7.3.1 Europe AI Pathological Diagnosis Platform Market Size by Application (2020-2031)
    • 7.3.2 Europe AI Pathological Diagnosis Platform Market Share by Application (2020-2031)
  • 7.4 Europe Market Size by Country
    • 7.4.1 Europe AI Pathological Diagnosis Platform Market Size by Country: 2020 VS 2024 VS 2031
    • 7.4.2 Europe AI Pathological Diagnosis Platform Market Size by Country (2020-2025)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 China

  • 8.1 China AI Pathological Diagnosis Platform Market Size (2020-2031)
  • 8.2 China Market Size by Type
    • 8.2.1 China AI Pathological Diagnosis Platform Market Size by Type (2020-2031)
    • 8.2.2 China AI Pathological Diagnosis Platform Market Share by Type (2020-2031)
  • 8.3 China Market Size by Application
    • 8.3.1 China AI Pathological Diagnosis Platform Market Size by Application (2020-2031)
    • 8.3.2 China AI Pathological Diagnosis Platform Market Share by Application (2020-2031)

9 Asia (excluding China)

  • 9.1 Asia AI Pathological Diagnosis Platform Market Size (2020-2031)
  • 9.2 Asia Market Size by Type
    • 9.2.1 Asia AI Pathological Diagnosis Platform Market Size by Type (2020-2031)
    • 9.2.2 Asia AI Pathological Diagnosis Platform Market Share by Type (2020-2031)
  • 9.3 Asia Market Size by Application
    • 9.3.1 Asia AI Pathological Diagnosis Platform Market Size by Application (2020-2031)
    • 9.3.2 Asia AI Pathological Diagnosis Platform Market Share by Application (2020-2031)
  • 9.4 Asia Market Size by Region
    • 9.4.1 Asia AI Pathological Diagnosis Platform Market Size by Region: 2020 VS 2024 VS 2031
    • 9.4.2 Asia AI Pathological Diagnosis Platform Market Size by Region (2020-2031)
    • 9.4.3 Japan
    • 9.4.4 South Korea
    • 9.4.5 China Taiwan
    • 9.4.6 Southeast Asia
    • 9.4.7 India
    • 9.4.8 Australia

10 Middle East, Africa, and Latin America

  • 10.1 Middle East, Africa, and Latin America AI Pathological Diagnosis Platform Market Size (2020-2031)
  • 10.2 Middle East, Africa, and Latin America Market Size by Type
    • 10.2.1 Middle East, Africa, and Latin America AI Pathological Diagnosis Platform Market Size by Type (2020-2031)
    • 10.2.2 Middle East, Africa, and Latin America AI Pathological Diagnosis Platform Market Share by Type (2020-2031)
  • 10.3 Middle East, Africa, and Latin America Market Size by Application
    • 10.3.1 Middle East, Africa, and Latin America AI Pathological Diagnosis Platform Market Size by Application (2020-2031)
    • 10.3.2 Middle East, Africa, and Latin America Market Share by Application (2020-2031)
  • 10.4 Middle East, Africa, and Latin America Market Size by Country
    • 10.4.1 Middle East, Africa, and Latin America AI Pathological Diagnosis Platform Market Size by Country: 2020 VS 2024 VS 2031
    • 10.4.2 Middle East, Africa, and Latin America AI Pathological Diagnosis Platform Market Size by Country (2020-2031)
    • 10.4.3 Brazil
    • 10.4.4 Mexico
    • 10.4.5 Turkey
    • 10.4.6 Saudi Arabia
    • 10.4.7 Israel
    • 10.4.8 GCC Countries

11 Key Players Profiles

  • 11.1 Philips Healthcare
    • 11.1.1 Philips Healthcare Company Details
    • 11.1.2 Philips Healthcare Business Overview
    • 11.1.3 Philips Healthcare AI Pathological Diagnosis Platform Introduction
    • 11.1.4 Philips Healthcare Revenue in AI Pathological Diagnosis Platform Business (2020-2025)
    • 11.1.5 Philips Healthcare Recent Development
  • 11.2 Roche Diagnostics
    • 11.2.1 Roche Diagnostics Company Details
    • 11.2.2 Roche Diagnostics Business Overview
    • 11.2.3 Roche Diagnostics AI Pathological Diagnosis Platform Introduction
    • 11.2.4 Roche Diagnostics Revenue in AI Pathological Diagnosis Platform Business (2020-2025)
    • 11.2.5 Roche Diagnostics Recent Development
  • 11.3 Siemens Healthineers
    • 11.3.1 Siemens Healthineers Company Details
    • 11.3.2 Siemens Healthineers Business Overview
    • 11.3.3 Siemens Healthineers AI Pathological Diagnosis Platform Introduction
    • 11.3.4 Siemens Healthineers Revenue in AI Pathological Diagnosis Platform Business (2020-2025)
    • 11.3.5 Siemens Healthineers Recent Development
  • 11.4 GE HealthCare
    • 11.4.1 GE HealthCare Company Details
    • 11.4.2 GE HealthCare Business Overview
    • 11.4.3 GE HealthCare AI Pathological Diagnosis Platform Introduction
    • 11.4.4 GE HealthCare Revenue in AI Pathological Diagnosis Platform Business (2020-2025)
    • 11.4.5 GE HealthCare Recent Development
  • 11.5 Paige AI
    • 11.5.1 Paige AI Company Details
    • 11.5.2 Paige AI Business Overview
    • 11.5.3 Paige AI AI Pathological Diagnosis Platform Introduction
    • 11.5.4 Paige AI Revenue in AI Pathological Diagnosis Platform Business (2020-2025)
    • 11.5.5 Paige AI Recent Development
  • 11.6 PathAI
    • 11.6.1 PathAI Company Details
    • 11.6.2 PathAI Business Overview
    • 11.6.3 PathAI AI Pathological Diagnosis Platform Introduction
    • 11.6.4 PathAI Revenue in AI Pathological Diagnosis Platform Business (2020-2025)
    • 11.6.5 PathAI Recent Development
  • 11.7 Proscia
    • 11.7.1 Proscia Company Details
    • 11.7.2 Proscia Business Overview
    • 11.7.3 Proscia AI Pathological Diagnosis Platform Introduction
    • 11.7.4 Proscia Revenue in AI Pathological Diagnosis Platform Business (2020-2025)
    • 11.7.5 Proscia Recent Development
  • 11.8 Aiforia Technologies
    • 11.8.1 Aiforia Technologies Company Details
    • 11.8.2 Aiforia Technologies Business Overview
    • 11.8.3 Aiforia Technologies AI Pathological Diagnosis Platform Introduction
    • 11.8.4 Aiforia Technologies Revenue in AI Pathological Diagnosis Platform Business (2020-2025)
    • 11.8.5 Aiforia Technologies Recent Development
  • 11.9 Ibex Medical Analytics
    • 11.9.1 Ibex Medical Analytics Company Details
    • 11.9.2 Ibex Medical Analytics Business Overview
    • 11.9.3 Ibex Medical Analytics AI Pathological Diagnosis Platform Introduction
    • 11.9.4 Ibex Medical Analytics Revenue in AI Pathological Diagnosis Platform Business (2020-2025)
    • 11.9.5 Ibex Medical Analytics Recent Development
  • 11.10 Agfa-Gevaert Group
    • 11.10.1 Agfa-Gevaert Group Company Details
    • 11.10.2 Agfa-Gevaert Group Business Overview
    • 11.10.3 Agfa-Gevaert Group AI Pathological Diagnosis Platform Introduction
    • 11.10.4 Agfa-Gevaert Group Revenue in AI Pathological Diagnosis Platform Business (2020-2025)
    • 11.10.5 Agfa-Gevaert Group Recent Development
  • 11.11 Indica Labs
    • 11.11.1 Indica Labs Company Details
    • 11.11.2 Indica Labs Business Overview
    • 11.11.3 Indica Labs AI Pathological Diagnosis Platform Introduction
    • 11.11.4 Indica Labs Revenue in AI Pathological Diagnosis Platform Business (2020-2025)
    • 11.11.5 Indica Labs Recent Development
  • 11.12 Deep Bio Inc.
    • 11.12.1 Deep Bio Inc. Company Details
    • 11.12.2 Deep Bio Inc. Business Overview
    • 11.12.3 Deep Bio Inc. AI Pathological Diagnosis Platform Introduction
    • 11.12.4 Deep Bio Inc. Revenue in AI Pathological Diagnosis Platform Business (2020-2025)
    • 11.12.5 Deep Bio Inc. Recent Development
  • 11.13 Visiopharm
    • 11.13.1 Visiopharm Company Details
    • 11.13.2 Visiopharm Business Overview
    • 11.13.3 Visiopharm AI Pathological Diagnosis Platform Introduction
    • 11.13.4 Visiopharm Revenue in AI Pathological Diagnosis Platform Business (2020-2025)
    • 11.13.5 Visiopharm Recent Development
  • 11.14 Techcyte
    • 11.14.1 Techcyte Company Details
    • 11.14.2 Techcyte Business Overview
    • 11.14.3 Techcyte AI Pathological Diagnosis Platform Introduction
    • 11.14.4 Techcyte Revenue in AI Pathological Diagnosis Platform Business (2020-2025)
    • 11.14.5 Techcyte Recent Development
  • 11.15 Hologic Inc.
    • 11.15.1 Hologic Inc. Company Details
    • 11.15.2 Hologic Inc. Business Overview
    • 11.15.3 Hologic Inc. AI Pathological Diagnosis Platform Introduction
    • 11.15.4 Hologic Inc. Revenue in AI Pathological Diagnosis Platform Business (2020-2025)
    • 11.15.5 Hologic Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
      • 13.1.1.1 Research Programs/Design
      • 13.1.1.2 Market Size Estimation
      • 13.1.1.3 Market Breakdown and Data Triangulation
    • 13.1.2 Data Source
      • 13.1.2.1 Secondary Sources
      • 13.1.2.2 Primary Sources
  • 13.2 Author Details
  • 13.3 Disclaimer